Charles Greg Guyer - Mar 14, 2025 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Mar 14, 2025
Transactions value $
-$1,397,619
Form type
4
Date filed
3/18/2025, 06:22 PM
Previous filing
Mar 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Tax liability -$1.4M -20.1K -22.96% $69.44 67.5K Mar 14, 2025 Direct
transaction BMRN Common Stock Award $0 +13.3K +19.71% $0.00 80.8K Mar 17, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Award $0 +30.9K $0.00 30.9K Mar 17, 2025 Common Stock 30.9K $71.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted March 17, 2025. Price not applicable.
F2 Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.